- Home
- HCWC vs SBFM Comparison
HCWC vs SBFM Comparison
Compare HCWC & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWC
- SBFM
- Stock Information
- Founded
- HCWC N/A
- SBFM 2006
- Country
- HCWC
- SBFM United States
- Employees
- HCWC 450
- SBFM N/A
- Industry
- HCWC
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- HCWC
- SBFM Health Care
- Exchange
- HCWC NYSE
- SBFM Nasdaq
- Market Cap
- HCWC 5.0M
- SBFM 4.6M
- IPO Year
- HCWC N/A
- SBFM N/A
- Fundamental
- Price
- HCWC $0.42
- SBFM $1.51
- Analyst Decision
- HCWC
- SBFM Strong Buy
- Analyst Count
- HCWC 0
- SBFM 1
- Target Price
- HCWC N/A
- SBFM $15.00
- AVG Volume (30 Days)
- HCWC N/A
- SBFM 104.8K
- Earning Date
- HCWC N/A
- SBFM 05-15-2025
- Dividend Yield
- HCWC N/A
- SBFM N/A
- EPS Growth
- HCWC N/A
- SBFM N/A
- EPS
- HCWC N/A
- SBFM N/A
- Revenue
- HCWC N/A
- SBFM $36,234,578.00
- Revenue This Year
- HCWC N/A
- SBFM $192.48
- Revenue Next Year
- HCWC N/A
- SBFM N/A
- P/E Ratio
- HCWC N/A
- SBFM N/A
- Revenue Growth
- HCWC N/A
- SBFM 35.51
- 52 Week Low
- HCWC N/A
- SBFM $1.17
- 52 Week High
- HCWC N/A
- SBFM $11.39
- Technical
- Relative Strength Index (RSI)
- HCWC N/A
- SBFM 54.20
- Support Level
- HCWC N/A
- SBFM $1.37
- Resistance Level
- HCWC N/A
- SBFM $1.56
- Average True Range (ATR)
- HCWC 0.00
- SBFM 0.08
- MACD
- HCWC 0.00
- SBFM 0.02
- Stochastic Oscillator
- HCWC 0.00
- SBFM 73.68
About HCWC HEALTHY CHOICE WELLNESS CORP
Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.